Overview

Definition:
-Inferior vena cava (IVC) filters are devices placed in the IVC to prevent pulmonary embolism (PE) in patients who cannot tolerate anticoagulation
-Peri-operative management encompasses the care provided before, during, and immediately after filter placement to optimize outcomes and minimize complications.
Epidemiology:
-PE is a significant cause of morbidity and mortality
-IVC filters are indicated in a subset of patients with deep vein thrombosis (DVT) or PE at high risk for recurrence and contraindication or failure of anticoagulation
-Incidence varies based on criteria and patient populations, with increasing utilization noted globally.
Clinical Significance:
-Effective peri-operative management is crucial for successful IVC filter placement, aiming to prevent life-threatening PE while mitigating procedural risks
-It involves careful patient selection, meticulous technique, and vigilant post-procedural monitoring
-Proper management ensures the filter achieves its intended prophylactic role and facilitates safe removal when no longer indicated.

Indications And Contraindications

Indications:
-Absolute indications include confirmed DVT or PE with documented contraindication to anticoagulation (e.g., active bleeding, recent surgery, hemorrhagic stroke)
-failure or recurrence of PE despite adequate anticoagulation
-Relative indications include massive PE with hemodynamic instability
-pulmonary hypertension secondary to chronic thromboembolic disease
-and prophylaxis in high-risk trauma patients.
Contraindications:
-Absolute contraindications include an IVC that is too small to accommodate the filter, severe coagulopathy that cannot be corrected, and absence of DVT or PE in a patient with a bleeding risk
-Relative contraindications may include caval anomalies, extensive thrombotic burden precluding safe passage of the filter, or concurrent systemic infection.
Patient Selection Criteria:
-Careful assessment of the risk of PE versus the risk of anticoagulation is paramount
-Guidelines from societies like the Society of Interventional Radiology (SIR) provide a framework for appropriate patient selection
-The presence of proximal DVT or PE and the patient's ability to tolerate anticoagulation are key determinants.

Preoperative Preparation

Medical Evaluation:
-Thorough review of patient history, including bleeding disorders, anticoagulant use, renal function (contrast administration), allergies, and comorbidities
-Assessment of cardiovascular and respiratory status
-Confirmation of IVC anatomy via imaging.
Imaging Studies:
-Venography (ilio-femoral) to delineate thrombus burden and IVC diameter
-CT or MRI may be used to assess IVC anatomy and rule out caval anomalies or existing thrombus extending into the suprarenal IVC.
Laboratory Tests:
-Complete blood count (CBC), coagulation profile (PT/INR, aPTT), renal function tests (creatinine, BUN)
-Type and screen for potential blood transfusion
-Pregnancy test for women of childbearing potential.
Anticoagulation Management:
-If the patient is on anticoagulation, strategies for peri-procedural management (e.g., bridging with heparin, holding specific agents) are determined based on the indication for filter placement and the procedural risk
-For patients with contraindication, this aspect is less critical but still requires assessment of potential for future anticoagulation.
Informed Consent:
-Detailed discussion with the patient and family about the procedure, its benefits, risks (e.g., filter migration, fracture, caval perforation, recurrent thrombosis, post-filter syndrome), alternatives, and expected outcomes
-Documentation of informed consent.

Perioperative Management During Procedure

Anesthesia And Sedation:
-Typically performed under local anesthesia with conscious sedation
-General anesthesia may be required for agitated patients or those undergoing concurrent procedures.
Access Site Preparation:
-Usually achieved via percutaneous access of the common femoral vein
-Site is prepped and draped sterilely
-Ultrasound guidance for venous access can improve success rates and reduce complications.
Procedural Technique:
-Guidewire and sheath insertion into the IVC
-Accurate filter deployment is critical, typically aiming for infrarenal placement
-Imaging (fluoroscopy, venography) is used to confirm appropriate position and filter deployment
-Caval venography post-deployment helps assess for thrombus burden and filter patency.
Anticoagulation During Procedure:
-Intravenous heparin is often administered during the procedure to maintain anticoagulation and reduce thrombotic complications
-Dosing is adjusted based on activated clotting time (ACT) if measured.
Monitoring:
-Continuous hemodynamic and oxygen saturation monitoring
-Close observation for any signs of adverse reaction to anesthesia, contrast media, or procedural complications.

Postoperative Care And Monitoring

Immediate Postoperative Care:
-Bed rest for a specified period (e.g., 4-6 hours) to minimize risk of bleeding at the access site
-Vital sign monitoring
-Assessment of pain and administration of analgesics
-Monitoring for signs of bleeding or hematoma at the access site.
Imaging And Follow Up:
-Post-procedure imaging (e.g., duplex ultrasound) of the access site to rule out pseudoaneurysm or deep vein thrombosis
-Serial imaging may be performed to assess filter position and patency, and to monitor for recurrent DVT/PE
-Long-term follow-up is essential for timely filter retrieval.
Anticoagulation Strategy:
-The decision regarding resumption or initiation of anticoagulation post-filter placement is individualized
-It depends on the initial indication for filter placement, the presence of residual thrombus, and the patient's bleeding risk
-Often, anticoagulation is resumed once bleeding risk has subsided.
Potential Complications Monitoring:
-Vigilance for signs of filter migration, embolization, caval perforation, tilting, or obstruction
-Monitoring for symptoms suggestive of post-filter syndrome (e.g., lower extremity edema, venous claudication).
Filter Retrieval Considerations:
-IVC filters are generally intended for temporary use
-A plan for retrieval should be established at the time of placement
-Retrieval is typically considered once the risk of PE has diminished and anticoagulation can be safely managed
-Delayed retrieval increases the risk of complications.

Complications Of Ivc Filter Placement

Early Complications:
-Access site complications (hematoma, bleeding, pseudoaneurysm)
-Arrhythmias during manipulation
-Allergic reaction to contrast
-Caval injury (perforation, dissection)
-Filter embolization or migration
-Acute IVC thrombosis.
Late Complications:
-Post-filter syndrome (chronic venous insufficiency, leg swelling, venous claudication)
-Filter fracture or detachment
-Recurrent DVT or PE despite filter
-Late caval occlusion
-Erosion through the caval wall.
Prevention And Management:
-Meticulous technique, appropriate patient selection, and judicious use of anticoagulation can mitigate risks
-Management of complications depends on the specific event
-for example, filter embolization may require surgical or interventional retrieval, while post-filter syndrome may require conservative management and compression therapy.

Key Points

Exam Focus:
-Indications for IVC filter placement are crucial
-Understand the difference between temporary and permanent filters
-Peri-operative management aims to optimize safety and efficacy
-Complications like migration, fracture, and post-filter syndrome are high-yield.
Clinical Pearls:
-Always document IVC filter placement and retrieval status in patient records
-Utilize imaging to confirm correct filter position and rule out complications
-Consider filter retrieval once the risk of PE has passed and anticoagulation is safe
-Ultrasound guidance for access improves outcomes.
Common Mistakes: Inappropriate patient selection, failure to perform adequate pre-procedural imaging, incorrect filter deployment leading to suboptimal position, inadequate post-operative monitoring, and failure to plan for filter retrieval.